⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Dennis SuarezMD

Rheumatology · Mayaguez, PR 00680

NPI: 1194785477

Share:

13

🟢 Low

Risk Flags

Elevated cost per beneficiaryOpioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

19,035

Total Claims

$7.5M

Drug Cost

1,519

Beneficiaries

$4,957

Cost/Patient

Risk Score Breakdown 13/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

-72%

Opioid rate vs peers

1.1% vs 4.1% avg

-18%

Cost per patient vs peers

$4,957 vs $6,039 avg

+22%

Brand preference vs peers

9.3% vs 7.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.1%

Opioid Rate

217

Opioid Claims

$1,420

Opioid Cost

Long-Acting Rate

Brand vs Generic

91% generic

Brand: 1,761 claims · $7.2M

Generic: 17,254 claims · $303K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Adalimumab269$1.9M
Etanercept258$1.8M
Abatacept177$968K
Golimumab60$360K
Tofacitinib Citrate47$266K
Upadacitinib42$260K
Etanercept30$216K
Adalimumab26$183K
Tocilizumab47$176K
Abatacept29$158K
Secukinumab20$143K
Etanercept19$135K
Secukinumab13$91K
Teriparatide19$81K
Sarilumab13$55K

Prescribing Profile

122

Unique Drugs

$2.2M

IRA Negotiated Drugs

13.0

Anomaly Score

Patient Profile

67

Avg Age

80%

Female

2.04

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About